View IPO
View IPOView Insights. Invest Better.
IPO AnalysisGMP TrackerNewLot CalculatorAllotment StatusHotBlogAEOTop Brokers
Get Started
100% Independent & Unbiased
No Broker or Bank Tie-ups
Secure & Private Data
Trusted by 10,000+ Investors

The Ultimate Retail Investor Advantage

ViewIPO is an independent financial research platform bridging the gap between institutional funds and everyday investors. We provide proprietary data aggregation including Live GMP Tracking, Smart Lot Size Calculators, unified Allotment Status Checkers, and AI-Powered Sentiment Analysis to give you a mathematical edge in the IPO market.

Read Our Full Story
View IPO
View IPO

View Insights. Invest Better.

The global IPO intelligence platform for smarter, data-backed investment decisions. Institutional-grade AI analysis across India.

Product

  • IPO Directory
  • IPO Calendar
  • GMP TrackerNew
  • Lot Calculator
  • Allotment StatusHot
  • Active IPOs
  • Upcoming IPOs
  • SME IPOs
  • Mainboard IPOs
  • Find Your BrokerComing soon

Markets & Brokers

  • India (SEBI / NSE / BSE)
  • Top Brokers
  • Zerodha Review
  • Upstox Review
  • Angel One Review
  • Groww Review
  • ICICI Direct
  • 5Paisa
  • Dhan

Resources

  • About Us
  • Blog & Insights
  • IPO Glossary
  • How It Works
  • Frequently Asked Questions
  • HTML Sitemap
  • Export IPO Calendar (.ics)Coming soon

Trust & Legal

  • Our AI Methodology
  • Data Sources
  • Privacy Policy
  • Terms of Service
  • Disclaimer

© 2026 View IPO. All rights reserved.

Regulatory Disclaimer: View IPO is an independent educational and research platform. We are NOT registered with the Securities and Exchange Board of India (SEBI) as an Investment Advisor or Research Analyst. All data, risk scores, and Grey Market Premium (GMP) figures are provided solely for informational purposes and do not constitute financial advice. We do not endorse or facilitate any transactions in the unofficial grey market. Please consult a SEBI-registered financial advisor before making any investment decisions.

View IPO
View IPOView Insights. Invest Better.
IPO AnalysisGMP TrackerNewLot CalculatorAllotment StatusHotBlogAEOTop Brokers
Get Started
Back to Blog
Market EducationAugust 11, 2026•
6 min read

Kostak Rate vs. Subject to Sauda (Sub2) Explained: A Grey Market Guide

Author

View IPO Research

Editorial Team

Share
Kostak Rate vs. Subject to Sauda (Sub2) Explained: A Grey Market Guide

Quick AnswerKostak Rate is the fixed premium paid for an IPO application regardless of whether shares are allotted. Subject to Sauda (Sub2) is the premium paid ONLY if the shares are successfully allotted to the application. Both are used in the unofficial Grey Market to gauge IPO demand.

What is the Unofficial Grey Market?

Before an Initial Public Offering (IPO) officially lists on stock exchanges like the BSE or NSE, its shares often trade in an unofficial, over-the-counter market known as the Grey Market. While trading unlisted shares is not regulated by SEBI, tracking Grey Market activity is highly popular among retail investors because it acts as a powerful sentiment indicator.

Within this market, two terms dominate the conversation: Kostak Rate and Subject to Sauda (Sub2). Understanding the difference between these two can help you accurately gauge institutional and high-net-worth investor (HNI) demand.

What is the Kostak Rate?

The Kostak Rate is the fixed premium paid by a buyer for an entire IPO application, regardless of whether the application receives an allotment or not.

For example, if you apply for an IPO and sell your application in the grey market at a Kostak rate of ₹2,000, the buyer pays you ₹2,000 upfront. If your application gets allotted, the buyer takes the shares and the listing gains. If you do not get an allotment, you still keep the ₹2,000, and the buyer takes the loss.

Why trade on Kostak?

For sellers, it completely eliminates risk. For buyers, it is a way to secure a position in highly oversubscribed IPOs where getting a direct allotment is mathematically difficult.

What is Subject to Sauda (Sub2)?

Subject to Sauda (often abbreviated as Sub2) is the premium agreed upon for an IPO application only if the shares are allotted.

For example, if the Subject to Sauda rate is ₹5,000, you agree to sell your application to a buyer. However, the deal is only valid if you actually win the allotment lottery. If you get zero shares, the deal is canceled, and no money exchanges hands.

Why choose Subject to Sauda?

Sub2 rates are generally much higher than Kostak rates because the buyer takes on zero allotment risk. They only pay the premium if the shares are successfully credited to the Demat account.

Kostak vs Subject to Sauda: Which is a Better Indicator?

While both metrics indicate demand, Subject to Sauda is generally considered a more accurate reflection of expected listing gains. When Sub2 rates spike heavily in the days leading up to the IPO allotment, it suggests that large buyers are desperate to acquire confirmed shares at a premium, predicting a massive listing day pop.

However, manually tracking these offline rates can be confusing and risky. Instead of relying on word-of-mouth, smart investors simply monitor the aggregated Grey Market Premium trend. You can instantly check the real-time, aggregated premiums and expected listing gains for any active issue using our Live IPO GMP Tracker.

The Bottom Line

Both Kostak and Subject to Sauda are unregulated grey market transactions. While it is not recommended to participate in these offline trades due to counterparty risks, tracking their rates is an excellent way to predict IPO listing performance. By keeping a close eye on the live GMP trends, you can make highly informed decisions on whether to apply for an upcoming IPO or skip it entirely.

Frequently Asked Questions

Is trading in the Grey Market (Kostak/Sub2) legal?

The Grey Market is an unofficial, over-the-counter market. While not strictly illegal, it is unregulated by SEBI, meaning there is zero legal protection against fraud or counterparty default.

Why is Subject to Sauda higher than Kostak?

Subject to Sauda removes the allotment risk for the buyer. Since the buyer only pays if shares are allotted, they are willing to offer a much higher premium compared to the Kostak rate.

Read Next

Who are Institutional Investors in an IPO? (QIBs & Anchor Investors)

Who are Institutional Investors in an IPO? (QIBs & Anchor Investors)

Understand the role of Qualified Institutional Buyers (QIBs) and Anchor Investors in deciding the success of an IPO.

Read Article
What is an IPO? Full Form, Meaning, and How It Works

What is an IPO? Full Form, Meaning, and How It Works

Understand the IPO full form, meaning, and why companies decide to go public to raise capital in the stock market.

Read Article
IPO Investment: How to Invest in Upcoming IPOs Safely

IPO Investment: How to Invest in Upcoming IPOs Safely

A beginner's guide to IPO investments. Learn how to evaluate companies, apply for shares, and minimize listing day risks.

Read Article
100% Independent & Unbiased
No Broker or Bank Tie-ups
Secure & Private Data
Trusted by 10,000+ Investors

The Ultimate Retail Investor Advantage

ViewIPO is an independent financial research platform bridging the gap between institutional funds and everyday investors. We provide proprietary data aggregation including Live GMP Tracking, Smart Lot Size Calculators, unified Allotment Status Checkers, and AI-Powered Sentiment Analysis to give you a mathematical edge in the IPO market.

Read Our Full Story
View IPO
View IPO

View Insights. Invest Better.

The global IPO intelligence platform for smarter, data-backed investment decisions. Institutional-grade AI analysis across India.

Product

  • IPO Directory
  • IPO Calendar
  • GMP TrackerNew
  • Lot Calculator
  • Allotment StatusHot
  • Active IPOs
  • Upcoming IPOs
  • SME IPOs
  • Mainboard IPOs
  • Find Your BrokerComing soon

Markets & Brokers

  • India (SEBI / NSE / BSE)
  • Top Brokers
  • Zerodha Review
  • Upstox Review
  • Angel One Review
  • Groww Review
  • ICICI Direct
  • 5Paisa
  • Dhan

Resources

  • About Us
  • Blog & Insights
  • IPO Glossary
  • How It Works
  • Frequently Asked Questions
  • HTML Sitemap
  • Export IPO Calendar (.ics)Coming soon

Trust & Legal

  • Our AI Methodology
  • Data Sources
  • Privacy Policy
  • Terms of Service
  • Disclaimer

© 2026 View IPO. All rights reserved.

Regulatory Disclaimer: View IPO is an independent educational and research platform. We are NOT registered with the Securities and Exchange Board of India (SEBI) as an Investment Advisor or Research Analyst. All data, risk scores, and Grey Market Premium (GMP) figures are provided solely for informational purposes and do not constitute financial advice. We do not endorse or facilitate any transactions in the unofficial grey market. Please consult a SEBI-registered financial advisor before making any investment decisions.